Medicare recipients will get a premium reduction – but not until next year – reflecting what Health and Human Services Secretary Xavier Becerra said Friday was an overestimate in costs of covering an expensive and controversial new Alzheimer’s drug.
More Stories
Trudeau: U.S. abortion ruling could mean loss of other rights
Canadian Prime Minister Justin Trudeau warned Saturday that the U.S. Supreme Court decision to overturn a constitutional right to abortion...
Pope hails families, blasts 'culture of waste' after Roe
Pope Francis celebrated families Saturday and urged them to shun "selfish" decisions that are indifferent to life as he closed...
75% of teens not getting enough exercise, study finds
New research indicates that a large majority of teens aren't getting enough exercise, particularly teenage girls.
NYC's monkeypox vaccine rollout halted by low supply
A limited supply of the monkeypox vaccine in New York City has stalled health officials' rollout soon just hours after...
Federal court pauses FDA ban on Juul products
Juul products aren't being taken off store shelves quite yet, thanks to a federal judge's order.
Monkeypox mutating more than previously thought, researchers say
The monkeypox outbreak has spread to 25 U.S. states and the District of Columbia. Portugal scientists warn about the possible...